Epicentre, Paris, France.
J Clin Microbiol. 2012 Aug;50(8):2788-90. doi: 10.1128/JCM.01232-12. Epub 2012 May 30.
Simple tuberculosis (TB) treatment monitoring tools are needed. We assessed the performance of fluorescein-diacetate (FDA) smear microscopy for detection of viable Mycobacterium tuberculosis in sputum specimens (n = 288) of TB cases under treatment compared to culture (17.4% culture positivity). FDA sensitivity was moderate (83.7% [95% confidence interval {CI}, 70.3 to 92.6]), and specificity was low (66.1% [59.5 to 72.2]). The good negative predictive value (94.8% [90.1 to 97.8]) and negative likelihood ratio (0.2) suggest using this method to rule out treatment failure in settings without access to culture.
需要简单的结核病(TB)治疗监测工具。我们评估了荧光素二乙酸酯(FDA)痰涂片显微镜检测在治疗中的结核病例(n=288)中检测活结核分枝杆菌的性能,与培养(17.4%的培养阳性率)相比。FDA 的灵敏度为中度(83.7%[95%置信区间(CI):70.3 至 92.6]),特异性较低(66.1%[59.5 至 72.2])。良好的阴性预测值(94.8%[90.1 至 97.8])和负似然比(0.2)表明,在无法进行培养的情况下,可使用该方法排除治疗失败的情况。